If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
ADRENALINE AGUETTANT 1:10,000 adrenaline (epinephrine) (as acid tartrate) 1 mg/10 mL solution for injection prefilled syringe AUST R: 282377Active ingredients:
adrenaline (epinephrine) acid tartrate
Dosage form:
Injection, solution
Sponsor:
Juno Pharmaceuticals Pty Ltd
Phone:
0388881288
|
From
18 Jul 2024
to
16 Sep 2024
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
The sponsor is working to expedite the next shipment. Other dosage forms are available.
|
ADRENALINE-LINK 1:10,000 1mg/10mL adrenaline (epinephrine) acid tartrate injection BP pre filled syringe AUST R: 210672Active ingredients:
adrenaline (epinephrine) acid tartrate
Dosage form:
Injection, solution
Sponsor:
Link Medical Products Pty Ltd T/A Link Pharmaceuticals
Phone:
1800181060
|
From
06 Aug 2024
to
20 Dec 2024
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
The sponsor is working to expedite the next shipment. Other dosage forms are available.
|
2% XYLOCAINE DENTAL WITH ADRENALINE 1:80,000 2.2mL injection cartridge AUST R: 12024Active ingredients:
adrenaline (epinephrine) acid tartrate
lidocaine hydrochloride monohydrate
Dosage form:
Injection, solution
Sponsor:
Dentsply Sirona Pty Ltd
Phone:
1300 552 929
|
From
14 Jun 2024
to
16 Aug 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
BUPIVADREN Bupivacaine 0.25% w/v with Adrenaline (epinephrine) 1:400,000 injection solution vial AUST R: 292526Active ingredients:
adrenaline (epinephrine) acid tartrate
bupivacaine hydrochloride monohydrate
Dosage form:
Injection, solution
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
From
02 Aug 2024
to
16 Aug 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
MARCAIN 0.25% WITH ADRENALINE 1:400,000 20mL injection vial AUST R: 125878Active ingredients:
adrenaline (epinephrine) acid tartrate
bupivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
From
27 May 2024
to
05 Jul 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
MARCAIN 0.5% WITH ADRENALINE 1:200,000 20mL injection vial AUST R: 48329Active ingredients:
adrenaline (epinephrine) acid tartrate
bupivacaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
From
27 May 2024
to
21 Jun 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|
BUPIVADREN Bupivacaine 0.5% w/v with Adrenaline (epinephrine) 1:200,000 injection solution vial AUST R: 292528Active ingredients:
adrenaline (epinephrine) acid tartrate
bupivacaine hydrochloride monohydrate
Dosage form:
Injection, solution
Sponsor:
Pfizer Australia Pty Ltd
Phone:
1800-675-229
|
Deletion from market:
31 Jan 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Alternative generic products are available.
|
XYLOCAINE 0.5% WITH ADRENALINE 1:200,000 20mL injection vial AUST R: 12008Active ingredients:
adrenaline (epinephrine) acid tartrate
lidocaine hydrochloride
Dosage form:
Injection, solution
Sponsor:
Aspen Pharmacare Australia Pty Ltd
Phone:
1300659646
|
Deletion from market:
12 Aug 2024
|
Shortage status:
Discontinued
Availability:
Unavailable
Reason:
Manufacturing
Management action:
Products are available in another presentation.
|